Year: 2008
Type: review
Abstract: Atherosclerosis is a chronic, progressive, inflammatory disease with a long asymptomatic phase. Disease progression can lead eventually to the occurrence of acute cardiovascular events such as myocardial infarction, unstable angina pectoris and sudden cardiac death. While the disease is still in a subclinical stage, however, the presence of atherosclerosis can be identified by several methods, including coronary angiography, intravascular ultrasonography, B-mode ultrasonography, computed tomography and magnetic resonance imaging. Based on the results of imaging studies, statin therapy can slow, halt or even reverse the progression of atherosclerotic disease, depending on the intensity of treatment. Whether to screen and treat patients for subclinical atherosclerosis remains controversial. Although atheromatous plaque burden reduction has not yet been definitively correlated with significant decreases in risk for acute coronary events in asymptomatic patients, statin therapy contributes significantly to the risk reduction observed in clinical trials in patients with and without overt coronary disease.
Author: P. P. Toth
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: subclinical atherosclerosis, atherosclerosis, asymptomatic cardiovascular disease, atherosclerotic plaque, plaque burden, statin therapy, cardiovascular risk reduction, atherosclerosis imaging, coronary angiography, intravascular ultrasound, computed tomography, magnetic resonance imaging, myocardial infarction, sudden cardiac death
Open Access status: bronze
Funder: AstraZeneca
OpenAlex ID: W2136834613
